Seizert Capital Partners’s Psychemedics Corporation PMD Stock Holding History

Seizert Capital Partners’s Portfolio PMD Stock Details PMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30,179	Closed	-$423K	–	239
2019 Q1	$423K	Hold	30,179	–	–	0.02%	173
2018 Q4	$479K	Hold	30,179	–	–	0.02%	155
2018 Q3	$568K	Buy	30,179 +7,015	+30%	+$140K	0.02%	154
2018 Q2	$495K	Hold	23,164	–	–	0.02%	158
2018 Q1	$495K	Sell	23,164 -12,116	-34%	-$252K	0.02%	158
2017 Q4	$725K	Sell	35,280 -5,475	-13%	-$102K	0.03%	133
2017 Q3	$751K	Buy	40,755 +11,077	+37%	+$244K	0.03%	139
2017 Q2	$740K	Buy	+29,678	New	+$624K	0.03%	140

Other funds holding PMD

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return

CIC

Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DRZID

DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UIC

Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Seizert Capital Partners's PMD Position: Q2 2019 in Review

Seizert Capital Partners sold out of Psychemedics Corporation (PMD) in Q2 2019, closing a stake of 30,179 shares — an estimated $423K sold.

Seizert Capital Partners first reported a position in PMD in Q2 2017 and held it in 8 quarters. The position peaked at $751K in Q3 2017. 46 funds tracked by Wall St. Rank hold PMD as of Q2 2019.

Seizert Capital Partners reported no remaining Psychemedics Corporation position as of Q2 2019 after selling out during the quarter.
Seizert Capital Partners sold 30,179 Psychemedics Corporation shares in Q2 2019, an estimated $423K.
Seizert Capital Partners first reported a position in Psychemedics Corporation in Q2 2017 and held it in 8 quarters.
Seizert Capital Partners's Psychemedics Corporation position peaked at $751K in Q3 2017.
46 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q2 2019.

Based on Seizert Capital Partners's 13F filing for Q2 2019, filed 6 Aug 2019.